Annual EBIT
-$51.79 M
-$8.93 M-20.85%
31 December 2023
Summary:
Acumen Pharmaceuticals annual earnings before interest & taxes is currently -$51.79 million, with the most recent change of -$8.93 million (-20.85%) on 31 December 2023. During the last 3 years, it has fallen by -$43.88 million (-554.58%). ABOS annual EBIT is now -563.55% below its all-time high of -$7.80 million, reached on 31 December 2019.ABOS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$28.74 M
-$9.21 M-47.13%
30 September 2024
Summary:
Acumen Pharmaceuticals quarterly earnings before interest & taxes is currently -$28.74 million, with the most recent change of -$9.21 million (-47.13%) on 30 September 2024. Over the past year, it has dropped by -$15.78 million (-121.80%). ABOS quarterly EBIT is now -2041.43% below its all-time high of -$1.34 million, reached on 01 December 2020.ABOS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$78.06 M
-$15.78 M-25.34%
30 September 2024
Summary:
Acumen Pharmaceuticals TTM earnings before interest & taxes is currently -$78.06 million, with the most recent change of -$15.78 million (-25.34%) on 30 September 2024. Over the past year, it has dropped by -$30.32 million (-63.51%). ABOS TTM EBIT is now -3715.25% below its all-time high of -$2.05 million, reached on 31 March 2020.ABOS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABOS EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.9% | -121.8% | -63.5% |
| 3 y3 years | -554.6% | -630.3% | -523.9% |
| 5 y5 years | - | - | - |
ABOS EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -554.6% | at low | -630.3% | at low | -523.9% | at low |
| 5 y | 5 years | -563.5% | at low | -2041.4% | at low | -3715.3% | at low |
| alltime | all time | -563.5% | at low | -2041.4% | at low | -3715.3% | at low |
Acumen Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$28.74 M(+47.1%) | -$78.06 M(+25.3%) |
| June 2024 | - | -$19.53 M(+40.8%) | -$62.28 M(+14.6%) |
| Mar 2024 | - | -$13.87 M(-12.8%) | -$54.36 M(+5.0%) |
| Dec 2023 | -$51.79 M(+20.8%) | -$15.92 M(+22.8%) | -$51.79 M(+8.5%) |
| Sept 2023 | - | -$12.96 M(+11.6%) | -$47.74 M(+3.4%) |
| June 2023 | - | -$11.61 M(+2.7%) | -$46.16 M(+2.7%) |
| Mar 2023 | - | -$11.31 M(-4.7%) | -$44.96 M(+4.9%) |
| Dec 2022 | -$42.86 M | -$11.87 M(+4.4%) | -$42.85 M(+8.8%) |
| Sept 2022 | - | -$11.37 M(+9.2%) | -$39.40 M(+23.3%) |
| June 2022 | - | -$10.41 M(+13.1%) | -$31.97 M(+27.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$9.21 M(+9.4%) | -$25.00 M(+27.6%) |
| Dec 2021 | -$19.58 M(+147.5%) | -$8.41 M(+113.9%) | -$19.58 M(+56.5%) |
| Sept 2021 | - | -$3.94 M(+14.4%) | -$12.51 M(+13.1%) |
| June 2021 | - | -$3.44 M(-9.3%) | -$11.07 M(+14.6%) |
| Mar 2021 | - | -$3.79 M(+182.6%) | -$9.66 M(+22.1%) |
| Dec 2020 | -$7.91 M(+1.4%) | - | - |
| Dec 2020 | - | -$1.34 M(-46.1%) | -$7.91 M(+20.4%) |
| Sept 2020 | - | -$2.49 M(+22.4%) | -$6.57 M(+61.0%) |
| June 2020 | - | -$2.04 M(-0.5%) | -$4.08 M(+99.5%) |
| Mar 2020 | - | -$2.05 M | -$2.05 M |
| Dec 2019 | -$7.80 M | - | - |
FAQ
- What is Acumen Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals annual EBIT year-on-year change?
- What is Acumen Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals quarterly EBIT year-on-year change?
- What is Acumen Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals TTM EBIT year-on-year change?
What is Acumen Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ABOS is -$51.79 M
What is the all time high annual EBIT for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high annual earnings before interest & taxes is -$7.80 M
What is Acumen Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ABOS annual earnings before interest & taxes has changed by -$8.93 M (-20.85%)
What is Acumen Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ABOS is -$28.74 M
What is the all time high quarterly EBIT for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$1.34 M
What is Acumen Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ABOS quarterly earnings before interest & taxes has changed by -$15.78 M (-121.80%)
What is Acumen Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ABOS is -$78.06 M
What is the all time high TTM EBIT for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high TTM earnings before interest & taxes is -$2.05 M
What is Acumen Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ABOS TTM earnings before interest & taxes has changed by -$30.32 M (-63.51%)